Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

SGMO

SGMO News

Newswire

04:08

Sangamo Therapeutics shares rise 10.41% premarket after FDA grants Fast Track designation for ST-503 in small fiber neuropathy.

09:20

Sangamo shares surge 32.13% premarket as FDA grants ST-503 Fast Track for small fiber neuropathy.

09:20

Sangamo shares surge 24.33% premarket after FDA grants Fast Track for ST-503 to treat small fiber neuropathy.

08:08

Sangamo Therapeutics receives FDA Fast Track Designation for ST-503 treatment.

08:06

Sangamo Therapeutics Receives FDA Fast Track Designation for ST-503 to Treat Intractable Pain Due to Small Fiber Neuropathy

View More

About SGMO

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More